AI Article Synopsis

  • The study aimed to assess how the application of modified natural elements, specifically yellow clay and a new clay-based treatment (glinofir), impacts immune regulation in an experimental model of adjuvant arthritis (AA).
  • Using Wistar rats divided into five groups, researchers tested the anti-inflammatory effects of different balneotherapeutic treatments applied before and during the AA progression, comparing results between treated and untreated groups.
  • Results showed that after 37 days of AA induction, there were significant changes in the rats' immune cell populations, with increases in B-lymphocytes and decreases in T-lymphocytes, particularly indicating that glinofir application positively influenced immune responses.

Article Abstract

Aim: The objective of the present study was to investigate the influence of a course of application of the modified natural factors on the immunological mechanisms of regulation under experimental conditions with special reference to the application of the natural yellow clay, the clay from the Novo-Pyatigorsk quarry (the lake Tambokan) and of the new balneotherapeutic preparation glinofir based on this modified clay and designed for the treatment of adjuvant arthritis (AA).

Material And Methods: The study of anti-inflammatory activity of the externally applied balneomedicines was carried out with the use of an animal model of adjuvant arthritis. The course of applications started 3 days prior to the initiation of AA and was terminated on the 24th day of the experimental disease. The action of three balneotherapeutic preparations (Tambukan mud, yellow clay, and modified clay in the form of Glinofir) was compared after they were heated to 42 °C and applied to the animals' limbs for 15-20 minutes every second and third days. The experiments were performed on Wistar rats (n=59) divided into five groups. Group 1 was comprised of 9 healthy animals that served as controls. The animals of group 2 (n=10) presented with untreated experimentally-induced adjuvant arthritis, those of Group 3 (n=10) had model AA treated by a course of application of the Tambukan mud. The animals of group 4 (n=10) had model AA and were treated by the application of the yellow clay and those of Group 5 (n=10) with model of AA received a course of application of the modified clay.

Results: On day 37 after the induction of adjuvant arthritis, the animals developed leukocytosis (white blood cell count in the blood was 1.5 times higher than in the control group) and alterations in the composition of the lymphocyte population, viz. B-lymphocytes increased 2-2.5 times (p<0,02) while T-lymphocytes decreased (p<0,05). A course of glinofir application contributed to the restoration of the T-cytotoxic cell population (p<0,2) and influenced the regulation of pathological immune complexes (PIC) as confirmed the negative correlation between the PIC level and the absolute number of T-cytotoxic cells (r=-0,8, p<0,01). The chronic stage of AA was associated with a two-fold increase in the absorptive capacity of neutrophils. The treatment with the Tambukan mud and glinofir restored the phagocytic function of neutrophils and simultaneously reduced the blood leukocyte reaction.

Conclusion: The anti-inflammatory action of the Tambukan mud and glinofir manifests itself in the unidirectional changes of dynamics of the characteristics of cellular and humoral immunity.

Download full-text PDF

Source
http://dx.doi.org/10.17116/kurort2016456-59DOI Listing

Publication Analysis

Top Keywords

adjuvant arthritis
16
group n=10
16
course application
12
yellow clay
12
n=10 model
12
balneotherapeutic preparation
8
preparation glinofir
8
treatment adjuvant
8
application modified
8
modified clay
8

Similar Publications

Current diagnosis and treatment of rheumatoid arthritis (RA) is still challenging. More than one-third of patients with RA could not be accurately diagnosed because of lacking biomarkers. Our recent study reported that scavenger receptor-A (SR-A) is a biomarker for RA, especially for anticyclic citrullinated peptide antibody (anti-CCP)-negative RA.

View Article and Find Full Text PDF

Introduction: Hepatitis B reactivation and administration of prophylactic antiviral treatment are considered in patients with autoimmune inflammatory rheumatic diseases (AIIRD) undergoing immunosuppressive/immunomodulatory treatment. Data are more robust for rheumatoid arthritis patients receiving bDMARDs but are limited for other AIIRD and drug categories.

Methods: Adult patients with AIIRD (inflammatory arthritis [IA] or connective tissue diseases [CTD]) and documented chronic or resolved HBV infection (defined as serum HBsAg positivity or anti-HBcAb positivity in the case of HBsAg non-detection respectively), followed-up in six rheumatology centers in Greece and Italy, were included.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a common autoimmune joint disease characterized by persistent synovial inflammation and cartilage damage. The current clinical treatments primarily utilize drugs such as triptolide (TP) to address inflammation, yet they are unable to directly repair damaged cartilage. Furthermore, the persistent inflammation often undermines the effectiveness of traditional cartilage repair strategies, preventing them from achieving optimal outcomes.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint swelling, pain, and bone remodeling. We previously reported that autotaxin (ATX) deficiency disrupts lipid rafts in macrophages. Lipid raft disruption results in the dysregulation of RANK signaling, which is crucial for osteoclastogenesis and the pathogenesis of RA.

View Article and Find Full Text PDF

Potential influence of different peri-operative analgesic regimens on tumour biology and outcome after oncologic surgery: A narrative review.

Eur J Anaesthesiol

December 2024

From the Département d'Anesthésie, Chirurgie et Interventionnel (LB), U1138 Metabolism, Cancer and Immunity, Gustave Roussy, Villejuif, France (LB), Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California, USA (LB), Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition (PF), Anaesthesia department, NHS Grampian, Aberdeen, UK (PF), IMAGINE UR UM 103, Montpellier University, Anesthesia Critical Care, Emergency and Pain Medicine Division, Nîmes University Hospital, Nîmes, France (PF), Pain and Opioids after Surgery (PANDOS) European Society of Anaesthesiology and Intensive Care (ID ESAIC_RG_PAND) Research Group, Brussels, Belgium (PF), Department of Anaesthesiology, Amsterdam UMC, Amsterdam, The Netherlands (MWH), School of Pharmacy, The University of Queensland, Pharmacy Australia Centre of Excellence, Woolloongabba Qld, Australia (M-OP), Department of Anaesthesiology and Intensive Care, University of Leipzig Medical Center, Leipzig, Germany (TP), EuroPeriscope, ESAIC Onco-Anaesthesiology Research Group, Brussels, Belgium (TP, LB, PF, MWH).

The management of peri-operative pain is one of the pillars of anaesthesia and is of particular importance in patients undergoing surgery for solid malignant tumours. Amongst several options, the most commonly employed analgesic regimens involve opioids, NSAIDs and regional anaesthesia techniques with different local anaesthetics. In recent years, several research reports have tried to establish a connection between peri-operative anaesthesia care and outcome after cancer surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!